Deep-tech pioneer Chemify – the University of Glasgow’s Spin-out of the Year 2024 – has officially opened its first Chemifarm, a groundbreaking £12 million production facility in Maryhill. Located at the 21,500‑ft² Oakbank Industrial Estate off Garscube Road in Glasgow, the site is set to accelerate the journey from molecular concept to compound, transforming laboratory research into tangible industrial innovation.
Founded in 2022 and emerging from Professor Lee Cronin’s pioneering research in digital chemistry, Chemify fuses cutting-edge advances in chemistry, robotics, computation, and AI. The new facility combines an AI-driven molecular design engine with industrial-scale robotic synthesis, significantly reducing the time and waste typically associated with traditional chemical production. Chemify claims that its Chemifarm is the most advanced chemical synthesis facility in the world, and it will eventually accommodate over 60 full-time scientists alongside hundreds of robots.
The plant is equipped with dedicated production suites, R&D laboratories, engineering and fabrication zones, and a secure cloud architecture designed to store petabytes of high-resolution chemical data for AI-powered analysis. It will also serve as a testbed for next-generation Chemifarm hardware intended for future global sites.
This milestone has garnered strong support from Innovate UK’s Innovation Accelerator programme, Scottish Enterprise, and Glasgow City Council, and it symbolizes the University of Glasgow’s commitment to transforming academic excellence into commercial success. At the opening, University Principal Sir Anton Muscatelli described the occasion as “a hugely significant milestone” in the University’s strategy to create jobs and boost the regional economy by translating cutting‐edge research into successful spin-out companies.
Chemify’s innovative platform is already making significant strides in tackling some of the world’s toughest challenges. Among its commercial partners is a collaboration, supported by the Gates Foundation, aimed at discovering new drug leads to address global health issues such as tuberculosis and malaria. By combining automation, AI, and scalable synthesis, Chemify is poised to revolutionize molecular innovation, enabling rapid progress in drug discovery, materials science, and beyond.
As the facility begins operations, Chemify’s rapid growth – from a small team working out of university labs to a workforce of around 130 staff – underscores its key role in Scotland’s emerging innovation economy. With plans to prototype future Chemifarm machines destined for global deployment, the company is well-positioned to strengthen Glasgow’s reputation as an international center of science and ingenuity while driving high-quality job creation and economic impact.
Experts and leaders across academia, industry, and government have hailed the launch. University Principal Sir Anton Muscatelli, Director for Place and Global at Innovate UK, Dean Cook, and Scottish Enterprise Chief Executive Adrian Gillespie have all highlighted Chemify’s transformative potential. Councillor Susan Aitken, Leader of Glasgow City Council and Chair of the Glasgow City Region Cabinet, emphasized that Chemify is a striking example of how the region is becoming a hub for innovation and advanced chemical production.
Chemify’s first Chemifarm is not just a facility—it is a bold vision for the future of chemical synthesis, one that promises to foster breakthroughs that may redefine both the pharmaceutical and materials science landscapes worldwide.